DE60032704D1 - Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit - Google Patents

Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Info

Publication number
DE60032704D1
DE60032704D1 DE60032704T DE60032704T DE60032704D1 DE 60032704 D1 DE60032704 D1 DE 60032704D1 DE 60032704 T DE60032704 T DE 60032704T DE 60032704 T DE60032704 T DE 60032704T DE 60032704 D1 DE60032704 D1 DE 60032704D1
Authority
DE
Germany
Prior art keywords
film
coated tablets
influence susceptibility
dependence
minimized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60032704T
Other languages
English (en)
Other versions
DE60032704T2 (de
Inventor
Peter Fyhr
Marta Corselli
Staffan Waxegard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Actavis Laboratories UT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Laboratories UT Inc filed Critical Actavis Laboratories UT Inc
Publication of DE60032704D1 publication Critical patent/DE60032704D1/de
Application granted granted Critical
Publication of DE60032704T2 publication Critical patent/DE60032704T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60032704T 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit Expired - Fee Related DE60032704T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection
SE9903879 1999-10-28

Publications (2)

Publication Number Publication Date
DE60032704D1 true DE60032704D1 (de) 2007-02-15
DE60032704T2 DE60032704T2 (de) 2007-10-11

Family

ID=20417507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032704T Expired - Fee Related DE60032704T2 (de) 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Country Status (5)

Country Link
EP (1) EP1095651B1 (de)
JP (1) JP4711499B2 (de)
DE (1) DE60032704T2 (de)
ES (1) ES2280192T3 (de)
SE (1) SE9903879D0 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
ZA200707250B (en) * 2005-01-27 2009-06-24 Alembic Ltd Extended release formulation of levetiracetam
RU2007139819A (ru) * 2005-03-29 2009-05-10 МакНЕЙЛ-Пи-Пи-Си, ИНК. (US) Композиции с гидрофильными лекарствами в гидрофобной среде
JP6042880B2 (ja) * 2011-06-01 2016-12-14 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 放出を制御された固形剤形
CN105188891B (zh) 2013-03-14 2017-11-24 陶氏环球技术有限责任公司 包括可溶性聚合物涂层的复合聚酰胺膜
CN116193994A (zh) * 2020-07-13 2023-05-30 麒麟控股株式会社 薄膜包衣片剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE47519T1 (de) * 1982-07-08 1989-11-15 Leo Ab Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung.
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
FI101344B (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
CA2163121A1 (en) * 1993-06-14 1994-12-22 Paul Marie Victor Gilis Extended release, film-coated tablet of astemizole and pseudoephedrine
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor

Also Published As

Publication number Publication date
SE9903879D0 (sv) 1999-10-28
JP2001131059A (ja) 2001-05-15
ES2280192T3 (es) 2007-09-16
JP4711499B2 (ja) 2011-06-29
EP1095651A3 (de) 2002-08-21
EP1095651B1 (de) 2007-01-03
EP1095651A2 (de) 2001-05-02
DE60032704T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
DE60003687D1 (de) Geschirrspülmaschine mit verbesserter architektur
BR9814000B1 (pt) artigo refletivo.
BR0012206B1 (pt) artigo fotocrâmico revestido e artigo fotocrâmico.
BR9917076B1 (pt) artigo e artigo fotocrÈmico.
ATE268165T1 (de) Didanosin tabletten mit magensaftresistentem überzug
BR9917067B1 (pt) artigo fotocrÈmico.
MA25492A1 (fr) Conteneurs fabriques en polycarbonate ramifie
ATE279413T1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
ID26052A (id) Barang berdaya serap
DK0966287T3 (da) Oxacarbazepinfilmovertrukne tabletter
DE60039046D1 (de) Lebensmittelprodukte mit biokontrollierter konservierung
DE69823190D1 (de) Plattenspieler mit selbstschliessendem tablett
ID23735A (id) Tablet trovafloksasin mesilat
DE60009168D1 (de) Behälter mit informationsanzeige
DE59905444D1 (de) Kochmulde mit anzeigeelementen
DE60032704D1 (de) Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit
DE69811027T2 (de) Zirkulator mit konzentrierten Elementen
IT1303258B1 (it) Lavastoviglie con ciclo di pre-riscaldamento.
FI3513U1 (fi) Myyntiteline
NO982198D0 (no) Nµringsmiddelprodukt med pastalag
ID25567A (id) Ulir-jepit dengan bahu-puntir
DE60032591D1 (de) Magnetische immersionslinse mit detektionsanordnung
NL1007992A1 (nl) Roteerbare sterilisatie-inrichting met verlengde agitatie.
DE29906564U1 (de) Schmuckstück mit gefaßtem Gegenstand

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee